BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7126234)

  • 1. Ganglioside GM1 sensitizes tumor cells to growth inhibitory glycopeptides.
    Kinders RJ; Rintoul DA; Johnson TC
    Biochem Biophys Res Commun; 1982 Jul; 107(2):663-9. PubMed ID: 7126234
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective protection of nonmalignant cells by a novel cell surface glycopeptide.
    McGee JE; Johnson B; Kinders R; Johnson TC
    Cancer Res; 1983 May; 43(5):2015-7. PubMed ID: 6831431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of gangliosides in the interaction of a growth inhibitor with mouse LM cells.
    Bascom CC; Sharifi BG; Melkerson LJ; Rintoul DA; Johnson TC
    J Cell Physiol; 1985 Dec; 125(3):427-35. PubMed ID: 4066767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycopeptides prepared from mouse cerebrum inhibit protein synthesis and cell division in baby hamster kidney cells, but not in their polyoma virus-transformed analogs.
    Kinders RJ; Johnson TC
    Exp Cell Res; 1981 Nov; 136(1):31-41. PubMed ID: 6271564
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat.
    Agnati LF; Benfenati F; Battistini N; Cavicchioli L; Fuxe K; Toffano G
    Acta Physiol Scand; 1983 Feb; 117(2):311-4. PubMed ID: 6869038
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: serum- and NGF-dependent effects on neuritic growth (and proliferation).
    Katoh-Semba R; Skaper SD; Varon S
    J Neurosci Res; 1984; 12(2-3):299-310. PubMed ID: 6502755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of exogenous GM1 and GD1a on S20Y neuroblastoma cells.
    Carine K; Schengrund CL
    J Neurosci Res; 1984; 12(1):59-69. PubMed ID: 6481820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive activity of glycosphingolipids. Influence of serum factors on ganglioside inhibition of IL-4-dependent cell proliferation.
    Molotkovskaya IM; Zelenova NA; Lutsenko GV; Sapozhnikov AM; Mikhalyov II; Molotkovsky JG
    Membr Cell Biol; 1999; 12(6):783-91. PubMed ID: 10512048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cell-surface glycopeptides from mouse cerebral cortex that inhibit cell growth and protein synthesis.
    Kinders RJ; Milenkovic AG; Nordin P; Johnson TC
    Biochem J; 1980 Sep; 190(3):605-14. PubMed ID: 7470072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous gangliosides enhance recovery from cns injury.
    Karpiak SE
    Adv Exp Med Biol; 1984; 174():489-97. PubMed ID: 6741742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gangliosides stimulate astroglial cell proliferation in the absence of serum.
    Katoh-Semba R; Facci L; Skaper SD; Varon S
    J Cell Physiol; 1986 Jan; 126(1):147-53. PubMed ID: 3944195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides inhibit platelet-derived growth-factor-stimulated increases in intracellular calcium in Swiss 3T3 cells.
    Guan Z; Stokes BT; Van Brocklyn J; Yates AJ
    Biochim Biophys Acta; 1992 Sep; 1136(3):315-8. PubMed ID: 1520706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gangliosides that modulate membrane protein function.
    Igarashi Y; Nojiri H; Hanai N; Hakomori S
    Methods Enzymol; 1989; 179():521-41. PubMed ID: 2560130
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversibility of ganglioside effects on astrocyte morphology.
    Dekker A; Manthorpe M; Varon S
    J Neurosci Res; 1990 Jul; 26(3):349-55. PubMed ID: 2398513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gangliosides GM1 and GD1a on structural and thermotropic properties of sonicated small 1,2-dipalmitoyl-L-alpha-phosphatidylcholine vesicles.
    Hinz HJ; Körner O; Nicolau C
    Biochim Biophys Acta; 1981 May; 643(3):557-71. PubMed ID: 6894700
    [No Abstract]   [Full Text] [Related]  

  • 16. Ganglioside-mediated metabolic synchronization of protein synthesis activity in cultured hepatocytes.
    Brodsky VY; Nechaeva NV; Zvezdina ND; Novikova TE; Gvasava IG; Fateeva VI; Prokazova NV; Golovanova NK
    Cell Biol Int; 2000; 24(4):211-22. PubMed ID: 10816322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
    Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
    Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiapoptotic effect of gangliosides on PC12 cells exposed to bacterial lipopolysaccharide].
    Bayunova LV; Parnova GG; Avrova NF
    Zh Evol Biokhim Fiziol; 2015; 51(2):88-94. PubMed ID: 26027381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce T-cell apoptosis.
    Das T; Sa G; Hilston C; Kudo D; Rayman P; Biswas K; Molto L; Bukowski R; Rini B; Finke JH; Tannenbaum C
    Cancer Res; 2008 Mar; 68(6):2014-23. PubMed ID: 18339884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganglioside GM1 and its semisynthetic lysogangliosides reduce glutamate neurotoxicity by a novel mechanism.
    Costa E; Armstrong D; Guidotti A; Kharlamov A; Kiedrowski L; Wroblewski JT
    Adv Exp Med Biol; 1993; 341():129-41. PubMed ID: 7906915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.